A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)
Public ClinicalTrials.gov record NCT05755438. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).
Study identification
- NCT ID
- NCT05755438
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 204 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 10, 2023 (Actual)
- Primary completion
- Oct 7, 2024 (Actual)
- Completion
- Aug 13, 2025 (Actual)
- Last update posted
- Aug 12, 2026
2023 – 2025
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists Phoenix | Phoenix | Arizona | 85006 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| First Oc Dermatology | Fountain Valley | California | 92708 | — |
| Dermatology Associates Pc | Rockville | Maryland | 20850 | — |
| Clarkston Medical Group | Clarkston | Michigan | 48346 | — |
| Revival Research Institute, Llc Troy | Troy | Michigan | 48084 | — |
| Medisearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| Wake Forest University | Winston-Salem | North Carolina | 27157 | — |
| UC Health, Llc | Cincinnati | Ohio | 45219 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Central Sooner Research | Norman | Oklahoma | 73071 | — |
| Dermatology Associates of Plymouth Meeting | Plymouth Meeting | Pennsylvania | 19462 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| International Clinical Research Tennessee Llc | Murfreesboro | Tennessee | 37130 | — |
| North Texas Center For Clinical Research Ntccr | Frisco | Texas | 75034 | — |
| Austin Institute For Clinical Research Aicr Pflugerville | Pflugerville | Texas | 78660 | — |
| Center For Clinical Studies | Webster | Texas | 77598 | — |
| Premier Clinical Research | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05755438, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2026 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05755438 live on ClinicalTrials.gov.